AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pirosia 20mg Injection

Prescription Icon
Prescription Required

Marketer

Biovensia Pharmaceutical

Salt Composition

Piroxicam (20mg)

Overview Pirosia 20mg Injection

An injection of 20mg of Pirosia provides analgesia for moderate to severe pain, particularly in musculoskeletal conditions accompanied by inflammation. Parenteral administration is preferred when oral intake is impractical, and should always be given by a qualified medical professional; self-injection is strictly prohibited. Dosage and treatment length are determined individually based on response and underlying condition, continuing until medically discontinued. Commonly reported adverse effects include local injection site reactions (pain, erythema, edema), nausea, abdominal pain, dyspepsia, diarrhea, cephalalgia, and vertigo. Persistent or worsening side effects necessitate immediate medical attention, and strategies for mitigation may be discussed with your physician. Prior to use, disclose any pre-existing conditions such as peptic ulcers, cardiovascular disease, hypertension, or hepatic/renal impairment. Complete disclosure of all concurrent medications is crucial due to potential interactions. This medication is contraindicated during pregnancy and lactation; consultation with a physician is mandatory before use in these circumstances. Prolonged therapy may necessitate routine monitoring of renal and hepatic function, as well as relevant blood parameters.

Primary Ingredients of Pirosia 20mg Injection

The provided text is "undefined," therefore no rewriting is possible.

Uses of Pirosia 20mg Injection

Analgesia

Major Benefits of Pirosia 20mg Injection:

The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Pirosia 20mg Injection:

  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Stomach pain
  • Nausea
  • Headache
  • Dizziness

How to use Pirosia 20mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Pirosia 20mg Injection works:

Pirosia 20mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators, thus alleviating pain and swelling.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Pirosia 20mg Injection concurrently with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Pirosia 20mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Pirosia 20mg Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Administering Pirosia 20mg Injection may induce drowsiness, blurred vision, or dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

For individuals with significant kidney impairment, administration of Pirosia 20mg Injection requires careful monitoring. A modified dosage of Pirosia 20mg Injection might be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Pirosia 20mg Injection, as dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Pirosia 20mg Injection :

Omit a Pirosia 20mg Injection dose? Seek medical advice immediately.

Facts to Know About Pirosia 20mg Injection

LabelValue
Pharmaceutical Category Compounds derived from enolic acids
Potential for Dependence None.
Type of Treatment Pain relievers

FAQs on Pirosia 20mg Injection

Piroxicam 20mg Injection and diclofenac are both analgesics. Piroxicam, though, is a non-selective COX inhibitor, targeting the enzyme responsible for inflammation and pain sensation, while diclofenac exhibits greater selectivity for COX-2. This enhanced selectivity in diclofenac is believed to reduce the incidence of adverse reactions relative to piroxicam.
Naproxen and Pirosia 20mg Injection are analgesic medications that inhibit cyclooxygenase (COX), an enzyme contributing to pain and inflammation. Clinical trials indicate comparable efficacy between the two. Nevertheless, naproxen exhibits a lower incidence of gastrointestinal adverse effects compared to Pirosia 20mg Injection.
Piroxicam injection (20mg) and meloxicam are analgesics that non-selectively inhibit cyclooxygenase, an enzyme mediating inflammation and pain. Clinical trials demonstrate comparable efficacy between the two drugs. Nevertheless, meloxicam exhibits a lower incidence of acute gastrointestinal adverse events compared to piroxicam injection.
Piroxicam injection (20mg) and ketoprofen are both analgesics, non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials indicate superior efficacy of topical ketoprofen gel over piroxicam injection. Furthermore, the gel demonstrated favorable patient acceptance.
Piroxicam 20mg Injection targets cyclooxygenase, an enzyme mediating inflammation and pain, unlike Tramadol, a centrally-acting analgesic with opioid-like properties. Tramadol carries a risk of dependence.
Piroxicam (as in Pirosia 20mg Injection) and nimesulide are both analgesics. Piroxicam, however, is a non-selective cyclooxygenase (COX) inhibitor, while nimesulide selectively inhibits COX-2. This selectivity in nimesulide is believed to reduce adverse reactions relative to piroxicam. Its use is contraindicated in children under 12.
Chikungunya typically doesn't cause a decrease in platelet count. However, analgesics such as piroxicam may heighten the risk of bleeding. Therefore, avoid taking Pirosia 20mg Injection or any pain medication if you experience fever with joint pain. Seek medical advice before using Pirosia 20mg Injection.
Piroxicam 20mg Injection and aspirin are distinct medications, though both are classified as COX (cyclooxygenase) inhibitors. Shared properties include anti-inflammatory and analgesic effects.
Concurrent administration of Pirosia 20mg Injection and dexamethasone is contraindicated due to their synergistic toxicity, elevating the likelihood of gastrointestinal ulceration.
Concurrent use of methocarbamol and Pirosia 20mg Injection is considered safe, lacking documented significant adverse interactions. However, physician consultation is advised prior to commencing either treatment.
Piroxicam 20mg injection and paracetamol may be used concurrently; no significant adverse interactions are documented. Consult your physician prior to commencing either treatment.
Indeed. The injectable formulation of Pirosia, at a 20mg dose, belongs to the non-steroidal anti-inflammatory drug (NSAID) class.
A sulfur-based medication, Pirosia 20mg Injection, may trigger significant adverse reactions in susceptible patients. Severe dermatological responses, including Stevens-Johnson syndrome, are possible. Allergic individuals should disclose their sensitivities to their physician.
Pirosia 20mg Injection does not act as an anticoagulant; it is an analgesic. Patients with hemorrhagic conditions should not use this medication.
Piroxicam 20mg Injection does not relax muscles. It's an analgesic that targets the COX enzyme (cyclooxygenase), which mediates inflammation and pain.
Pirosia 20mg Injection is a non-narcotic analgesic. Its mechanism of action involves inhibiting COX enzymes, thereby reducing pain and inflammation.
Pirosia 20mg Injection does not manage high blood pressure. Concomitant use with antihypertensive drugs reduces their efficacy. Disclose any antihypertensive medication use to your physician prior to commencing Pirosia 20mg Injection.
Concurrent administration of Pirosia 20mg Injection and Losartan is contraindicated. Pirosia 20mg Injection diminishes the antihypertensive efficacy of Losartan, potentially resulting in treatment failure. Disclose any current antihypertensive medication use to your physician prior to commencing Pirosia 20mg Injection.
Concurrent use of Piroxicam 20mg Injection and lisinopril is contraindicated. Piroxicam reduces the efficacy of antihypertensive drugs such as lisinopril, potentially compromising blood pressure control. Disclose any antihypertensive medication use to your physician prior to commencing Piroxicam 20mg Injection therapy.
Affirmative. Concurrent administration of Pirosia 20mg Injection and calcium channel blockers is permissible. Studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) diminish the efficacy of most antihypertensive medications; however, this effect is not observed with calcium channel blockers (White, 2007).
Tizanidine can be safely administered concurrently with Pirosia 20mg Injection. Piroxicam, an analgesic, and the muscle relaxant tizanidine are frequently used together to manage conditions such as back pain.
Affirmative. The administration of Piroxicam 20mg Injection alongside beta-cyclodextrin is feasible. Studies indicate this combination accelerates the onset of piroxicam's therapeutic effect while mitigating gastrointestinal adverse reactions.
Indeed, viable alternatives to Piroxicam 20mg injections exist. Analgesic selection depends on the specific ailment. Physician consultation is necessary prior to commencing piroxicam therapy or switching to another treatment.
Piroxicam is contraindicated in patients with allergies, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores, systemic lupus erythematosus, ulcerative colitis, upper gastrointestinal problems, late-term pregnancy, heart conditions, liver dysfunction, or kidney impairment.
Pirosia 20mg Injection does not alleviate allergic reactions; it is an analgesic.
The injectable formulation of Piroxicam, 20mg, provides extended pain relief. While a single daily dose may suffice for some, individual responses vary; optimal analgesic effects with piroxicam generally emerge after several weeks of administration.
Pirosia 20mg Injection does not induce hypertension. This medication is a non-opioid analgesic.
The 20mg Pirosia injection lacks approval for managing dysmenorrhea. However, research indicates piroxicam offers substantial relief from menstrual pain.
The medication Pirosia 20mg Injection lacks regulatory approval for migraine management. Clinical trials indicate Pirosia 20mg Injection effectively reduces migraine pain in patients without aura.
Affirmative. This medication may alleviate back pain. Nevertheless, determining the underlying cause of your back pain requires a physician's consultation before treatment commences. Avoid self-administering Pirosia 20mg Injection; back pain etiology varies individually.
Indeed, a 20mg Pirosia injection is an appropriate treatment option for acute gout. Clinical trials have demonstrated its significant efficacy in managing acute gout attacks.
Blood donation is permissible while using Pirosia 20mg Injection; however, it's crucial to inform your physician beforehand.
Administering Piroxicam 20mg injection to a diabetic patient requires prior medical consultation. Prolonged use of this medication increases the risk of kidney failure. Since diabetes is itself a risk factor for renal impairment, the addition of piroxicam significantly elevates this risk.
Individuals with impaired kidney function should avoid Pirosia 20mg Injection. Prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) is linked to kidney damage, including papillary necrosis.
Skin reactions, potentially severe and even life-threatening, are a known side effect of Pirosia 20mg Injection. These reactions can include exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). Serious reactions may arise unexpectedly. Report any mild rash to your physician and stop using the medication immediately.
Administration of Pirosia 20mg Injection is contraindicated during pregnancy. Its use is associated with premature closure of the ductus arteriosus, potentially resulting in fetal cardiac failure and neonatal mortality.
Pirosia 20mg Injection is not suitable for patients with active peptic ulcers. This injection is associated with the potential for gastric ulceration and hemorrhage.
Individuals with asthma may experience heightened sensitivity to non-steroidal anti-inflammatory medications, such as aspirin, potentially triggering severe asthma episodes. Seek medical advice prior to commencing treatment with these drugs.
Affirmative. The injectable formulation of Piroxicam (20mg) has been linked to instances of temporary infertility. Its pharmacological action potentially interferes with the release of ovarian follicles, a phenomenon sometimes resulting in reversible infertility. Physician consultation is advised prior to commencing treatment.
Pirosia 20mg Injection is contraindicated for concurrent use with diuretics. In certain individuals, Pirosia 20mg Injection lessens the sodium-excreting action of furosemide and thiazide diuretics. This effect is believed to result from the suppression of renal prostaglandin production.
The drug Pirosia 20mg Injection must not be administered concurrently with lithium. Its use elevates lithium concentrations in the blood while diminishing the kidneys' ability to eliminate lithium. This effect stems from the nonsteroidal anti-inflammatory drug's (NSAID) suppression of renal prostaglandin production. Physician consultation is mandatory prior to initiating Pirosia 20mg Injection therapy.
Concurrent use of Pirosia 20mg Injection and warfarin is contraindicated due to the heightened risk of hemorrhage. Patients should disclose warfarin use to their physician prior to Pirosia administration. If co-administered, close clinical monitoring is essential.
Gastric ulcer risk rises with the use of medications such as corticosteroids and anticoagulants. Prolonged medication use, alcohol consumption, tobacco use, and advanced age are additional contributing factors to this increased risk.
Individuals experiencing asthma, urticaria, or other allergic responses to aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), or analgesics, either immediately preceding or following coronary artery bypass grafting.
Gastrointestinal distress, and in uncommon instances, severe gastrointestinal adverse reactions including peptic ulcers and hemorrhage; severe cutaneous reactions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis; hepatic failure; and kidney impairment.
Pirosia 20mg Injection
20
MRP 25
18% off